Assessing speech disorders in patients treated for oral or oropharyngeal cancer
Official title: Validity of a Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer
Run by University Hospital, Toulouse · NCT04742998 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing how well people who have been treated for oral or throat cancer can speak, using a special task to see if it helps understand their speech problems better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 116 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Marseille and 2 other locations) |
| Trial ID | NCT04742998 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include native French-speaking adults aged 18 and older who have been treated for oral or oropharyngeal cancer and are in clinical remission.
✕Probably not a fit
Patients with additional pathologies affecting speech or fluency disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate speech intelligibility in patients who have undergone treatment for oral or oropharyngeal cancer. It utilizes an acoustic-phonetic decoding task to objectively assess speech production and perception, bridging the gap between the two. The study hypothesizes that automatic processing of this task will provide reliable diagnostic insights into oropharyngeal deficits. Participants will be assessed based on their ability to produce isolated pseudo-words, with scores correlated to anatomical and functional speech deficits.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic tools for assessing speech disorders in cancer patients, enhancing their rehabilitation.
How similar studies have gone: While the approach is innovative, similar studies have shown promise in using objective measures for speech assessment in oncology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged at least 18 years old and benefiting from a social security scheme * Native French-speaking patients * Patients treated for cancer of the oral cavity or oropharynx (surgical and / or radiotherapy and / or chemotherapy treatment) * Patients in clinical remission for at least 6 months (chronic nature and stability of the disorders) * All tumor sizes according to the tumor (T), node (N), and metastasis (M) categories (TNM classification) (T1 to T4) * Patients with a perceptible speech disorder in a conversational situation or not (to allow the determination of fine deficits) * Patients who do not object to carrying out the research Exclusion Criteria: * Patients with an associated pathology potentially responsible for speech or fluency disorders (joint, speech and language disorders of developmental, organic or functional origin, voice disorders of organic or functional origin, stammering , stammering, fluency disturbances, speech disturbances of neurological origin) * Patients reporting an auditory complaint and not having a hearing aid * Inability to provide the person with enlightened information and to ensure the subject's compliance because of impaired physical and / or psychological health, * Patients participating in another research including an exclusion period still in progress.
Where it's running
-
AP- H Marseille - Hôpital de la Conception
Marseille, France Recruiting -
University Hospital Toulouse
Toulouse, France Recruiting -
Institut universitaire du Cancer de Toulouse - Oncopole
Toulouse, France Not yet recruiting
Study contacts
- Principal investigator: Clémence DEVOUCOUX — University Hospital, Toulouse
- Study coordinator: Clémence DEVOUCOUX
- Email: devoucoux.c@chu-toulouse.fr
- Phone: 06.50.72.24.85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how cochlear implant users hear speech in noise
This study is trying to see how cochlear implant users hear speech in noisy places by looking at their brain activity compared to people with normal hearing.
-
Group singing benefits for older adults with hearing loss
This study tests if group singing can help older adults with mild-to-moderate hearing loss feel better and understand speech in noisy environments compared to joining an audiobook club.
-
Using smart hearing aids to assess and reduce fall risk while improving speech clarity
This study is testing smart hearing aids that can help older adults not only hear better but also see if they can reduce the risk of falls by tracking their movements and activities.
-
Improving speech understanding in older adults through cognitive training
This study is testing a new training program to help older adults aged 65 to 85 understand speech better in noisy places.
-
Improving speech clarity in children with cerebral palsy using augmentative communication
This test checks whether having children with cerebral palsy point to letters or pictures while they speak can make their speech easier to understand.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.